iRhythm Technologies vs Abbott Laboratories: Fair Value & Quality
Both stocks run through our valuation models. Here is how iRhythm Technologies (IRTC) and Abbott Laboratories (ABT) compare, as of Aug 14, 2026.
As of Aug 14, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: iRhythm Technologies trades at $123 versus a fair value of $10.03 (-92%), while Abbott Laboratories trades at $111 versus $74.79 (-33%).
iRhythm Technologies
IRTC · USD · Health Care
-92%
upside to fair value
overvalued
Price$123
Fair Value$10.03
Quality47/100
Abbott Laboratories
ABT · USD · Health Care
-33%
upside to fair value
overvalued
Price$111
Fair Value$74.79
Quality67/100
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
iRhythm TechnologiesAbbott Laboratories
Valuation
—P/E (TTM)27.7×
4.69×P/S (TTM)3.89×
24.17×P/B3.36×
—EV/EBITDA15.1×
—PEG1.47×
Profitability
-4%Net margin14%
-6%Operating margin13%
-22%Return on equity12%
-1%Return on assets6%
Growth
26%Revenue growth (YoY)8%
22.1%Avg. growth/yr (3Y)0.5%
23.0%Avg. growth/yr (5Y)5.1%
Balance & size
4.25×Debt / equity0.19×
$4BMarket cap$175B
mixedGrowth qualityhealthy
Abbott Laboratories leads: 3 to 7 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
iRhythm Technologiesof which business quality 48 · market factors 26Abbott Laboratoriesof which business quality 66 · market factors 53
ProfitabilityMargins and returns on capital today
30
50
Quality GrowthAre margins and returns improving?
93
47
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
59
65
Low VolatilityCalm price path (market factor)
40
83
MomentumPrice trend over the last 3–12 months (market factor)
24
43
52W MomentumDistance to the 52-week high (market factor)
13
38
Net IssuanceBuybacks instead of dilution
57
84
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
iRhythm Technologies
DCF Models$42.38
Dividend Discount$41.39
Multiples$3.45
Asset-Based$10.03
Growth DCF$43.47
9 of 9 models see the stock below the current price.
Abbott Laboratories
DCF Models$73.01
Earnings-Based$29.42
Dividend Discount$39.73
Multiples$70.72
Asset-Based$20.05
Growth DCF$67.02
Economic Profit$37.49
Growth Earnings$70.25
26 of 26 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
iRhythm Technologies
Bear $2.61Fair Value $10.03Bull $10.03
$123 = current price (white tick)
Abbott Laboratories
Bear $51.13Fair Value $74.79Bull $94.43
$111 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
iRhythm Technologies · Health Care
Quality score47 · below median
Fair value upside-92% · bottom 25%
Abbott Laboratories · Health Care
Quality score67 · Top 25%
Fair value upside-33% · below median
Bottom line
As of Aug 14, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: iRhythm Technologies trades at $123 versus a fair value of $10.03 (-92%), while Abbott Laboratories trades at $111 versus $74.79 (-33%).
Abbott Laboratories has the higher quality score (67/100).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
